A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies (CEA(6D)VRP)
This study has been completed.
Sponsor:
AlphaVax, Inc.
Collaborator:
Duke University
Information provided by (Responsible Party):
AlphaVax, Inc.
ClinicalTrials.gov Identifier:
NCT00529984
First received: September 12, 2007
Last updated: July 11, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2010 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |